LRRK2 and Parkinson disease: A relatively small number of studies to date suggest that LRRK2 levels are not sufficiently altered in sporadic PD to allow for patient stratification, and the direct measurement of LRRK2 in living brain cells is not currently possible; the extent to which peripheral measures of LRRK2 inform on central nervous system pathobiology still needs to be determined.